Correction to: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European Journal of Human Genetics, (2022), 30, 3, (349-362), 10.1038/s41431-021-00987-7)

GEMO Study Collaborators; GC-HBOC study Collaborators; EMBRACE Collaborators; OPAL Study Group; AOCS Group; kConFab Investigators; HEBON Investigators; OCAC Consortium; CIMBA Consortium

doi:10.1038/s41431-022-01085-y

Correction to: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European Journal of Human Genetics, (2022), 30, 3, (349-362), 10.1038/s41431-021-00987-7)

GEMO Study Collaborators
, GC-HBOC study Collaborators
, EMBRACE Collaborators
, OPAL Study Group
, AOCS Group
, kConFab Investigators
, HEBON Investigators
, OCAC Consortium
, CIMBA Consortium

Instituto de Genética Humana

Department of Public Health and Primary Care
Department of Oncology
Cedars-Sinai Medical Center
Radboud University Nijmegen
Antoni van Leeuwenhoek Hospital
Istituto Oncologico Veneto – IRCCS
Mount Sinai Hospital of University of Toronto
University of Toronto
University of California, Irvine
The N.N. Alexandrov Research Institute of Oncology and Medical Radiology
'Agii Anargiri' Cancer Hospital
MD Anderson Cancer Center
Clinical Epidemiology Unit
Vall d'Hebron University Hospital
Vall d’Hebron Hospital
Rutgers Cancer Institute of New Jersey
Department of Pathology
Faculty of Medicine, University of Iceland
University Hospital Erlangen
Vanderbilt-Ingram Cancer Center
Centre for Biomedical Research on Rare Diseases (CIBERER)
Centro de Investigación en Red de Enfermedades Raras
Russian Academy of Sciences
Princess Margaret Hospital
Haukeland University Hospital
University of Bergen
National Cancer Institute (NCI)
Hannover Medical School
European Institute of Oncology
Skane University Hospital
University of Cambridge
M.Sklodowska-Curie Cancer Centre
University of Helsinki
Huntsman Cancer Institute
University Hospital of Pisa
University of Melbourne
Roswell Park Cancer Institute
Ohio State University
German Cancer Research Center
University of Hamburg
Tianjin Medical University
The University of Sydney
Westmead Hospital
Columbia University
Ghent University Hospital
University of New Mexico
Alberta Health Services
Mayo Clinic Rochester, MN
Fox Chase Cancer Center
Memorial Sloan-Kettering Cancer Center
Department of Tumour Biology
The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)
Hospital Clinico San Carlos
NorthShore University HealthSystem
The University of Chicago
Leiden University
Oncogenetics Group
Beckman Research Institute of City of Hope
University of Pennsylvania Health System
Kliniken Essen-Mitte
Dr. Horst Schmidt Klinik GmbH
Jena University Hospital
University of Southampton, Faculty of Medicine
Harvard T.H. Chan School of Public Health
Brigham and Women’s Hospital
Leipzig University
University of Manchester
Manchester University NHS Foundation Trust
Imperial College London
Masaryk Memorial Cancer Institute
Chaim Sheba Medical Center Israel
Tel Aviv University
University of California at Los Angeles
Dana-Farber Cancer Institute
University of Florence
Monash University
University of Kansas
Pomeranian Medical University in Szczecin
University of Cologne
Keck School of Medicine of USC
Karolinska Institutet
Rigshospitalet
University of Washington
National University of Singapore
National University Health System
Berlin Institute of Health
Danish Cancer Society
University of Copenhagen
Melbourne School of Population and Global Health
University of British Columbia
University of British Columbia, Faculty of Medicine
BC Cancer Research Centre
N.N. Petrov Institute of Oncology
Georgetown University
Peter Maccallum Cancer Centre
Vilnius University
State Research Institute Centre for Innovative Medicine
Stanford University
Institute of Cancer Research
Seoul National University
Seoul National University Cancer Research Institute
University of California at Davis
Medical University of South Carolina
St. Petersburg State University
Sungkyunkwan University School of Medicine
Cancer Genetics Centre
The University of Hong Kong
Hong Kong Sanatorium & Hospital
VIB Department of Molecular Microbiology
KU Leuven
Institute Catala Oncologia
Cancer Control Research
Institut Curie
Mines ParisTech
PSL Research University
NYU Langone Medical Center
Genome Institute of Singapore
University of Pittsburgh
IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
Duke University Hospital
University of Hawaii Cancer Center
Aichi Cancer Center Hospital and Research Institute
Nagoya University
Public Health Ontario
University of Glasgow
University College London
University of Pittsburgh Cancer Institute
Oregon Health and Science University
National Cancer Centre Singapore
Nanyang Technological University
Odense University Hospital
Latvian Biomedical Research and Study Centre
National Institute of Oncology
University Hospitals Leuven
QIMR Berghofer Medical Research Institute
Aalborg University
North Region Cancer Registry, Portuguese Oncology Institute
H. Lee Moffitt Cancer Center & Research Institute
FIRC Institute of Molecular Oncology
Bashkir State University
Yale University
National Institute of Environmental Health Sciences (NIEHS)
Fundación Pública Galega Medicina Xenómica
University of Santiago de Compostela
Université Laval Research Center
Hebei Medical University
Icahn School of Medicine at Mount Sinai
Medical University of Vienna
Royal Alexandra Hospital, Edmonton
INSERM U830
Université Paris Descartes
Morsani College of Medicine
University of Porto
Cancer Research Malaysia
University of Malaya
Mailman School of Public Health
McGill University
Dartmouth College
University of Oxford
Beth Israel Deaconess Medical Center
University of Groningen
University of Pretoria
Complejo Hospitalario Universitario de Santiago
Vanderbilt University Medical Center
Duke Cancer Institute
Clinical Cancer Genomics
Fred Hutchinson Cancer Research Center
Stanford University School of Medicine
Uppsala University
Demokritos National Centre for Scientific Research
Charles University
FL
University of New South Wales
University of Michigan, Ann Arbor
Rollins School of Public Health

Producción: Contribución a una revista › Comentario/Debate

3 Citas (Scopus)

Resumen

Correction to: European Journal of Human Genetics (2021) 30:349-362 https://doi.org/10.1038/s41431-021-00987-7, published online 14 January 2022 The wrong Supplementary files were originally published with this article; it has now been replaced with the correct files.

Idioma original	Inglés
Páginas (desde-hasta)	630-631
Número de páginas	2
Publicación	European Journal of Human Genetics
Volumen	30
N.º	5
DOI	https://doi.org/10.1038/s41431-022-01085-y
Estado	Publicada - may 2022

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.1038/s41431-022-01085-y

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

GEMO Study Collaborators, GC-HBOC study Collaborators, EMBRACE Collaborators, OPAL Study Group, AOCS Group, kConFab Investigators, HEBON Investigators, OCAC Consortium, & CIMBA Consortium (2022). Correction to: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European Journal of Human Genetics, (2022), 30, 3, (349-362), 10.1038/s41431-021-00987-7). European Journal of Human Genetics, 30(5), 630-631. https://doi.org/10.1038/s41431-022-01085-y

@article{53b90323ab5a41caa605b7ba417f99df,

title = "Correction to: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European Journal of Human Genetics, (2022), 30, 3, (349-362), 10.1038/s41431-021-00987-7)",

abstract = "Correction to: European Journal of Human Genetics (2021) 30:349-362 https://doi.org/10.1038/s41431-021-00987-7, published online 14 January 2022 The wrong Supplementary files were originally published with this article; it has now been replaced with the correct files.",

author = "\{GEMO Study Collaborators\} and \{GC-HBOC study Collaborators\} and \{EMBRACE Collaborators\} and \{OPAL Study Group\} and \{AOCS Group\} and \{kConFab Investigators\} and \{HEBON Investigators\} and \{OCAC Consortium\} and \{CIMBA Consortium\} and Dareng, \{Eileen O.\} and Tyrer, \{Jonathan P.\} and Barnes, \{Daniel R.\} and Jones, \{Michelle R.\} and Xin Yang and Aben, \{Katja K.H.\} and Adank, \{Muriel A.\} and Simona Agata and Andrulis, \{Irene L.\} and Hoda Anton-Culver and Antonenkova, \{Natalia N.\} and Gerasimos Aravantinos and Arun, \{Banu K.\} and Annelie Augustinsson and Judith Balma{\~n}a and Bandera, \{Elisa V.\} and Barkardottir, \{Rosa B.\} and Daniel Barrowdale and Beckmann, \{Matthias W.\} and Alicia Beeghly-Fadiel and Javier Benitez and Marina Bermisheva and Bernardini, \{Marcus Q.\} and Line Bjorge and Amanda Black and Bogdanova, \{Natalia V.\} and Bernardo Bonanni and Ake Borg and Brenton, \{James D.\} and Agnieszka Budzilowska and Ralf Butzow and Buys, \{Saundra S.\} and Hui Cai and Caligo, \{Maria A.\} and Ian Campbell and Rikki Cannioto and Hayley Cassingham and Jenny Chang-Claude and Chanock, \{Stephen J.\} and Kexin Chen and Chiew, \{Yoke Eng\} and Chung, \{Wendy K.\} and Claes, \{Kathleen B.M.\} and Sarah Colonna and Cook, \{Linda S.\} and Couch, \{Fergus J.\} and Daly, \{Mary B.\} and Fanny Dao and Eleanor Davies and Diana Torres",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = may,

doi = "10.1038/s41431-022-01085-y",

language = "English",

volume = "30",

pages = "630--631",

journal = "European Journal of Human Genetics",

issn = "1018-4813",

publisher = "Springer Nature",

number = "5",

}

GEMO Study Collaborators, GC-HBOC study Collaborators, EMBRACE Collaborators, OPAL Study Group, AOCS Group, kConFab Investigators, HEBON Investigators, OCAC Consortium & CIMBA Consortium 2022, 'Correction to: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European Journal of Human Genetics, (2022), 30, 3, (349-362), 10.1038/s41431-021-00987-7)', European Journal of Human Genetics, vol. 30, n.º 5, pp. 630-631. https://doi.org/10.1038/s41431-022-01085-y

Correction to: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European Journal of Human Genetics, (2022), 30, 3, (349-362), 10.1038/s41431-021-00987-7). / GEMO Study Collaborators; GC-HBOC study Collaborators; EMBRACE Collaborators et al.
En: European Journal of Human Genetics, Vol. 30, N.º 5, 05.2022, p. 630-631.

Producción: Contribución a una revista › Comentario/Debate

TY - JOUR

T1 - Correction to

T2 - Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European Journal of Human Genetics, (2022), 30, 3, (349-362), 10.1038/s41431-021-00987-7)

AU - GEMO Study Collaborators

AU - GC-HBOC study Collaborators

AU - EMBRACE Collaborators

AU - OPAL Study Group

AU - AOCS Group

AU - kConFab Investigators

AU - HEBON Investigators

AU - OCAC Consortium

AU - CIMBA Consortium

AU - Dareng, Eileen O.

AU - Tyrer, Jonathan P.

AU - Barnes, Daniel R.

AU - Jones, Michelle R.

AU - Yang, Xin

AU - Aben, Katja K.H.

AU - Adank, Muriel A.

AU - Agata, Simona

AU - Andrulis, Irene L.

AU - Anton-Culver, Hoda

AU - Antonenkova, Natalia N.

AU - Aravantinos, Gerasimos

AU - Arun, Banu K.

AU - Augustinsson, Annelie

AU - Balmaña, Judith

AU - Bandera, Elisa V.

AU - Barkardottir, Rosa B.

AU - Barrowdale, Daniel

AU - Beckmann, Matthias W.

AU - Beeghly-Fadiel, Alicia

AU - Benitez, Javier

AU - Bermisheva, Marina

AU - Bernardini, Marcus Q.

AU - Bjorge, Line

AU - Black, Amanda

AU - Bogdanova, Natalia V.

AU - Bonanni, Bernardo

AU - Borg, Ake

AU - Brenton, James D.

AU - Budzilowska, Agnieszka

AU - Butzow, Ralf

AU - Buys, Saundra S.

AU - Cai, Hui

AU - Caligo, Maria A.

AU - Campbell, Ian

AU - Cannioto, Rikki

AU - Cassingham, Hayley

AU - Chang-Claude, Jenny

AU - Chanock, Stephen J.

AU - Chen, Kexin

AU - Chiew, Yoke Eng

AU - Chung, Wendy K.

AU - Claes, Kathleen B.M.

AU - Colonna, Sarah

AU - Cook, Linda S.

AU - Couch, Fergus J.

AU - Daly, Mary B.

AU - Dao, Fanny

AU - Davies, Eleanor

AU - Torres, Diana

PY - 2022/5

Y1 - 2022/5

N2 - Correction to: European Journal of Human Genetics (2021) 30:349-362 https://doi.org/10.1038/s41431-021-00987-7, published online 14 January 2022 The wrong Supplementary files were originally published with this article; it has now been replaced with the correct files.

AB - Correction to: European Journal of Human Genetics (2021) 30:349-362 https://doi.org/10.1038/s41431-021-00987-7, published online 14 January 2022 The wrong Supplementary files were originally published with this article; it has now been replaced with the correct files.

UR - https://www.scopus.com/pages/publications/85130080421

U2 - 10.1038/s41431-022-01085-y

DO - 10.1038/s41431-022-01085-y

M3 - Comment/debate

C2 - 35314806

AN - SCOPUS:85130080421

SN - 1018-4813

VL - 30

SP - 630

EP - 631

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

IS - 5

ER -

GEMO Study Collaborators, GC-HBOC study Collaborators, EMBRACE Collaborators, OPAL Study Group, AOCS Group, kConFab Investigators et al. Correction to: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European Journal of Human Genetics, (2022), 30, 3, (349-362), 10.1038/s41431-021-00987-7). European Journal of Human Genetics. 2022 may;30(5):630-631. doi: 10.1038/s41431-022-01085-y

Correction to: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European Journal of Human Genetics, (2022), 30, 3, (349-362), 10.1038/s41431-021-00987-7)

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto